PubMed

C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy.

Ekberg K, Brismar T, Johansson BL, Lindström P, Juntti-Berggren L, Norrby A, Berne C, Arnqvist HJ, Bolinder J, Wahren J.

Diabetes Care. 2007 Jan;30(1):71-6.PMID: 17192336 [PubMed - indexed for MEDLINE]Related articlesFree article

Amelioration of sensory nerve dysfunction by C-Peptide in patients with type 1 diabetes.

Ekberg K, Brismar T, Johansson BL, Jonsson B, Lindström P, Wahren J.

Diabetes. 2003 Feb;52(2):536-41.PMID: 12540632 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy.

Reljanovic M, Reichel G, Rett K, Lobisch M, Schuette K, Möller W, Tritschler HJ, Mehnert H.

Free Radic Res. 1999 Sep;31(3):171-9.PMID: 10499773 [PubMed - indexed for MEDLINE]Related articles

Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy.

Bril V, Buchanan RA.

Diabetes Care. 2006 Jan;29(1):68-72.PMID: 16373898 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.

Vinik AI, Bril V, Kempler P, Litchy WJ, Tesfaye S, Price KL, Bastyr EJ 3rd; MBBQ Study Group.

Clin Ther. 2005 Aug;27(8):1164-80.PMID: 16199243 [PubMed - indexed for MEDLINE]Related articles

Effect of C-peptide on diabetic neuropathy in patients with type 1 diabetes.

Ekberg K, Johansson BL.

Exp Diabetes Res. 2008;2008:457912. Review.PMID: 18350117 [PubMed - indexed for MEDLINE]Related articlesFree article

Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C beta inhibitor, ruboxistaurin.

Brooks B, Delaney-Robinson C, Molyneaux L, Yue DK.

J Diabetes Complications. 2008 Mar-Apr;22(2):88-95.PMID: 18280438 [PubMed - indexed for MEDLINE]Related articles

Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus.

Johansson BL, Borg K, Fernqvist-Forbes E, Kernell A, Odergren T, Wahren J.

Diabet Med. 2000 Mar;17(3):181-9.PMID: 10784221 [PubMed - indexed for MEDLINE]Related articles

C-peptide improves neuropathy in type 1 diabetic BB/Wor-rats.

Zhang W, Kamiya H, Ekberg K, Wahren J, Sima AA.

Diabetes Metab Res Rev. 2007 Jan;23(1):63-70.PMID: 16845685 [PubMed - indexed for MEDLINE]Related articles

Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy. A long-term, randomised, double-blind, placebo-controlled study.

De Grandis D, Minardi C.

Drugs R D. 2002;3(4):223-31.PMID: 12455197 [PubMed - indexed for MEDLINE]Related articles

Ratio of motor nerve conduction velocity to F-wave conduction velocity in diabetic neuropathy.

Ohgaki K, Nakano K, Shigeta H, Kitagawa Y, Nakamura N, Iwamoto K, Makino M, Takanashi Y, Kajiyama S, Kondo M.

Diabetes Care. 1998 Apr;21(4):615-8.PMID: 9571352 [PubMed - indexed for MEDLINE]Related articlesFree article

Near normoglycaemia improved nerve conduction and vibration sensation in diabetic neuropathy.

Service FJ, Rizza RA, Daube JR, O'Brien PC, Dyck PJ.

Diabetologia. 1985 Oct;28(10):722-7.PMID: 3905469 [PubMed - indexed for MEDLINE]Related articles

A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy.

Casellini CM, Barlow PM, Rice AL, Casey M, Simmons K, Pittenger G, Bastyr EJ 3rd, Wolka AM, Vinik AI.

Diabetes Care. 2007 Apr;30(4):896-902.PMID: 17392551 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group.

Apfel SC, Schwartz S, Adornato BT, Freeman R, Biton V, Rendell M, Vinik A, Giuliani M, Stevens JC, Barbano R, Dyck PJ.

JAMA. 2000 Nov 1;284(17):2215-21.PMID: 11056593 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of one year of near-normoglycemia on peripheral nerve function in type 1 (insulin-dependent) diabetic patients.

Ziegler D, Wiefels K, Dannehl K, Gries FA.

Klin Wochenschr. 1988 May 2;66(9):388-96.PMID: 2839729 [PubMed - indexed for MEDLINE]Related articles

Ranirestat for the management of diabetic sensorimotor polyneuropathy.

Bril V, Hirose T, Tomioka S, Buchanan R; Ranirestat Study Group.

Diabetes Care. 2009 Jul;32(7):1256-60. Epub 2009 Apr 14.PMID: 19366965 [PubMed - indexed for MEDLINE]Related articlesFree article

Exercise-induced conduction velocity increment: a marker of impaired peripheral nerve blood flow in diabetic neuropathy.

Tesfaye S, Harris ND, Wilson RM, Ward JD.

Diabetologia. 1992 Feb;35(2):155-9.PMID: 1547920 [PubMed - indexed for MEDLINE]Related articles

Clinical utility of dorsal sural nerve conduction studies in healthy and diabetic children.

Turgut N, Karasalihoglu S, Kücükugurluoglu Y, Balci K, Ekuklu G, Tütüncüler F.

Clin Neurophysiol. 2004 Jun;115(6):1452-6.PMID: 15134714 [PubMed - indexed for MEDLINE]Related articles

Subclinical nerve dysfunction in children and adolescents with IDDM.

Hyllienmark L, Brismar T, Ludvigsson J.

Diabetologia. 1995 Jun;38(6):685-92.PMID: 7672490 [PubMed - indexed for MEDLINE]Related articles

C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.

Sima AA, Zhang W, Sugimoto K, Henry D, Li Z, Wahren J, Grunberger G.

Diabetologia. 2001 Jul;44(7):889-97.PMID: 11508275 [PubMed - indexed for MEDLINE]Related articles